Carbapenem is an important therapy for serious hospital‐acquired infections and for the
care of patients affected by multidrug‐resistant organisms, specifically Acinetobacter …

Purpose This article is the first to review published reports on the prevalence of multidrug-
resistant (MDR) gram-negative infections in Egypt and gain insights into antimicrobial …

The modified carbapenem inactivation method (mCIM) recommended by the Clinical and
Laboratory Standards Institute is not applicable for detecting carbapenemases in …

Carbapenemases are β-lactamase enzymes that hydrolyze a variety of β-lactams including
carbapenem and belong to different Ambler classes (A, B, D). These enzymes can be …

Background: Acinetobacter baumannii is a common cause of multi-drug (MDR)-resistant
infections worldwide. The epidemiological and molecular characteristics of MDR-A …

Carbapenem resistant Acinetobacter baumannii is a major global concern, especially in
countries of the Middle East and North Africa, where the antibiotic resistance rates are on the …

The relationship between the multidrug-resistant (MDR) phenotype and biofilm-forming
capacity has been a topic of extensive interest among biomedical scientists, as these two …

The worldwide spread of carbapenem-resistant Acinetobacter baumannii (CRAB) has
become a healthcare challenge for some decades. To understand its molecular …

Acinetobacter baumannii is a problematic pathogen of global concern. It causes multiple
types of infection, especially among immunocompromised individuals in intensive care units …

Carbapenem-resistant Acinetobacter baumannii infections are becoming increasingly
difficult to treat. Thus, this paper focused on identification of carbapenemase genes in …